Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis

T Pitre, K Drover, D Chaudhuri… - Critical care …, 2024 - journals.lww.com
OBJECTIVES: To perform a systematic review and meta-analysis to assess the efficacy and
safety of corticosteroids in patients with sepsis. DATA SOURCES: We searched PubMed …

Safety of steroids in severe community-acquired pneumonia

FV Piedepalumbo, A Motos, F Blasi… - European Respiratory …, 2025 - publications.ersnet.org
The systemic use of corticosteroids for patients with severe community-acquired pneumonia
(sCAP) remains controversial in clinical practice, particularly in terms of the safety profile of …

2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia

D Chaudhuri, AM Nei, B Rochwerg, RA Balk… - Critical care …, 2024 - journals.lww.com
2024 Focused Update: Guidelines on Use of Corticosteroids in... : Critical Care Medicine 2024
Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress …

Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial

N Heming, A Renault, E Kuperminc… - The Lancet …, 2024 - thelancet.com
Background Glucocorticoids probably improve outcomes in patients hospitalised for
community acquired pneumonia (CAP). In this a priori planned exploratory subgroup …

Recent temporal trends, characteristics and outcomes of patients with non‐COVID‐19 community‐acquired pneumonia at two tertiary hospitals in Australia: an …

Y Sharma, AA Mangoni, R Shahi… - Internal medicine …, 2024 - Wiley Online Library
Background Community‐acquired pneumonia (CAP) leads to considerable morbidity and
mortality globally. However, data on CAP burden in Australia, especially during the …

Association of cumulative methylprednisolone dosages with mortality risk from pneumonia in connective tissue disease patients

S Wang, Q Ye - Scientific Reports, 2024 - nature.com
Corticosteroid is essential in the treatment regimen for connective tissue disease (CTD);
however, its long-term use poses significant risks, including pulmonary infections. The …

Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis

XY See, TH Wang, YC Chang, J Lo… - BMJ Open …, 2024 - bmjopenrespres.bmj.com
Objectives Randomised controlled trials (RCTs) have demonstrated conflicting results
regarding the effects of corticosteroids on the treatment of severe community-acquired …

Comparing the efficacy of corticosteroids among patients with community-acquired pneumonia in the ICU versus non-ICU settings: A systematic review and meta …

LAD Caballero, A Aijaz, NS Paryani, S Mahmood… - Steroids, 2024 - Elsevier
Background Despite the potential of corticosteroids in treating community-acquired
pneumonia (CAP), conflicting evidence exists regarding their effect on mortality. To address …

Adverse Effects Related to Corticosteroid Use in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia: A Systematic Review and Meta …

D Chaudhuri, L Israelian, Z Putowski… - Critical care …, 2024 - journals.lww.com
OBJECTIVES: We postulate that corticosteroid-related side effects in critically ill patients are
similar across sepsis, acute respiratory distress syndrome (ARDS), and community-acquired …

The effect and safety of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis of randomized controlled trials

Y Chen, H Kuang, Y Zhu, X Luo - Frontiers in Medicine, 2024 - frontiersin.org
Background There is ongoing debate on the efficacy and safety of corticosteroid therapy for
severe community-acquired pneumonia (sCAP). Our aim was to investigate the safety and …